Lataa...
Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study
AIMS: A postmarketing Prescription-Event Monitoring study was undertaken to monitor the safety of rofecoxib, a cyclo-oxygenase (COX)-2 selective inhibitor prescribed in primary care in England. METHODS: Questionnaires requesting clinical event data were sent to prescribing physicians between Februar...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Science Inc
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1894735/ https://ncbi.nlm.nih.gov/pubmed/12580988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01763.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|